What are the Early Symptoms of Scleroderma? PDF Print E-mail
Wednesday, 07 July 2010 15:49
Scleroderma is a term used to describe a group of rare, chronic diseases characterized by unusual tightening and hardening of the connective tissues and skin. There are two major types of scleroderma: localized, which only affects the skin; and systemic, which affects the internal organs in addition to the skin.

Health officials at MayoClinic.com report that Native American or African-American females are most likely to be affected by this condition. The early symptoms of scleroderma can vary between patients and should be discussed with a doctor if they occur.

Skin Swelling, Thickening or Tightening
Patients with scleroderma can develop abnormal skin changes as a symptom of this condition. The fingers or hands can appear unusually puffy or enlarged and may develop thick patches of skin. Skin across the face or hands can become abnormally tight, which may lead to difficult or restricted movement of the affected body regions, explain health officials at MayoClinic.com. Patients may notice that the affected skin appears shiny or is hard or firm to the touch. These scleroderma symptoms may be mild initially but can become progressively worse over time.

Skin Discoloration
Unusual, sudden skin discoloration in response to cold temperatures can occur as a symptom of scleroderma. This symptom, which is referred to as Raynaud's phenomenon, is characterized by an abnormal white, blue or red discoloration of the skin along the fingers and toes caused by restricted blood flow to these body regions. Patients who experience Raynaud's phenomenon often develop sensations of numbness or pain within the hands and feet. These symptoms are typically temporary but can reoccur sporadically throughout the day, explains the Merck Manual, an online medical encyclopedia for health professionals. Severe emotional trauma or upset may also instigate Raynaud's phenomenon symptoms in certain patients.

Joint or Muscle Pain
Scleroderma can cause inflammation of the joints or muscles of patients during the early stages of this disease. As a result, affected patients can experience sensations of pain or aching throughout the body. These painful symptoms may occur in conjunction with muscle weakness, which can lead to difficulty standing or walking.

Gastroesophageal Reflux Disease
Patients with scleroderma can develop early symptoms of gastroesophageal reflux disease, or GERD. GERD symptoms can include heartburn, nausea, difficulty swallowing, chest discomfort or sore throat. Certain patients can experience a decrease in appetite that may be accompanied by bowel movement changes. Over time, these early symptoms of scleroderma can become worse and may lead to poor nutrient absorption and difficulty controlling stool production, a condition called fecal incontinence.

Source: Livestrong.com
 
More articles :

» Low-Dose Naltrexone for Pruritus in Systemic Sclerosis

Tracy Frech, Kirsten Novak, Monica P. Revelo, Maureen Murtaugh, Boaz Markewitz, Nathan Hatton, Mary Beth Scholand, Edward Frech, David Markewitz, and Allen D. SawitzkeReceived 31 May 2011; Accepted 14 July 2011Systemic sclerosis (SSc; scleroderma)...

» TLR4 Protein Implicated In The Fibrosis Associated With Scleroderma

An international multi-disciplinary research team led by scientists has uncovered a new role for the protein toll-like receptor 4 (TLR4) in the development of tissue fibrosis, or scarring.Recently reported in the , this finding has implications for...

» Rare Disease Research Teams Receive Over $17m In Funding

(CIHR) has formed 9 new research teams that will focus on rare diseases. Funding from the CIHR will total $15.4 million over five years, primarily through the Institute of Genetics and the Institute of Nutrition, Metabolism, and Diabetes, while...

» Facing Life's Challenges

At 57 years of age Anne Wersching doesn’t have a single wrinkle on her face.Sitting in her lounge room in Bayswater North, Ms Wersching looks well, save for a few red marks on her cheeks.But Ms Wersching has a little-known disease called...

» Skin Autofluorescence Is Not Increased in Patients with Systemic Sclerosis

M. E. Hettema, H. Bootsma, R. Graaff, R. de Vries, C. G. M. Kallenberg, and A. J. SmitReceived 24 May 2011; Accepted 8 August 2011Vascular involvement is a key factor in major manifestations of systemic sclerosis (SSc), such as Raynaud’s...

» Role of N-terminal Brain Natriuretic Peptide in Scleroderma-associated Pulmonary Arterial Hypertension

Mark H. Williams, Clive E. Handler, Raza Akram, Colette J. Smith, Clare Das, Joanna Smee, Devaki Nair, Christopher P. Denton, Carol M. Black and John G. CoghlanFirst published online: April 27, 2006Source: